Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Trial of Coenzyme Q10 in Mitochondrial Disease
NCT00432744Phase 3Completed
- Sponsor
- University of Florida
- Start
- Jan 2007
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of coenzyme q10 in mitochondrial disease (2 arms), sponsored by University of Florida. Primary endpoints: McMaster Gross Motor Function Measure 88 at 12 months, Pediatric Quality of Life Scale at 12 months and 1 more. Started Jan 2007; status: completed.
02
Drugs
coenzyme q10
03
Conditions
mitochondrial disease
Beyond the preview
Go deeper on NCT00432744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00432744.